Pharmacom Labs DRO E 200mg/ml 10 Ampoules

£69.00

Description
Reviews (0)

Pharmacom Labs DRO E 200mg/ml 10 Ampoules

Pharmacom Labs DRO E 200mg/ml 10 Ampoules deliver pharmaceutical–grade Drostanolone Enanthate, an extended-release version of the legendary Masteron compound. This sophisticated formulation provides the same hardening and defining effects as Drostanolone Propionate but features a significantly longer half-life of approximately 7–10 days. The extended release profile requires fewer injections while maintaining stable blood levels, making it perfect for longer cycles where consistent hormonal support is essential. Unlike aromatizing compounds, Drostanolone cannot convert to estrogen and exhibits no estrogenic activity whatsoever. This unique characteristic eliminates risks of gynecomastia and subcutaneous water retention while actively displaying anti-estrogenic traits that help manage estrogen levels from other stacked compounds. The lipolytic effect of Drostanolone Enanthate allows athletes to achieve excellent conditioning and definition by actively burning adipose tissue while preserving lean muscle mass. Additionally, the compound possesses a moderate diuretic effect that further enhances muscle density, separation, and vascularity by reducing excess fluid beneath the skin.

These properties make it highly recommended for track and field athletes and competitive bodybuilders who need to maintain specific weight classes while maximizing performance and aesthetics. The 10 ampoule package provides a complete sterile supply for extended protocols, ensuring precise dosing and maximum potency throughout the cycle. This longer-acting ester combines synergistically with other long-acting testosterone and trenbolone esters such as PHARMA TEST E 300, E 500, C 250, PHARMA TREN E 200, and PHARMA TREN H 100, creating powerful stacks for contest preparation or advanced physique refinement. Users experience granite-hard muscle tissue, enhanced vascularity, and a dry, ripped appearance without the bloating associated with other anabolic agents.

Key Features

Extended Release: 7–10 day half-life requires fewer injections than propionate versions
10 Sterile Ampoules: Glass ampoules ensure purity and precise dosing for long cycles
Zero Estrogen Activity: Cannot aromatize; exhibits anti-estrogenic properties preventing gynecomastia
Lipolytic Effect: Actively burns fat while preserving lean muscle tissue
Diuretic Properties: Moderate diuretic effect enhances muscle density and vascularity
Weight Class Optimization: Ideal for athletes needing strength without weight gain
Stacking Synergy: Combines perfectly with long-acting testosterone and trenbolone esters
Contest Preparation: Creates dry, defined, granite-hard musculature for competition

Product Specifications

Product Name: PHARMA DRO E 200
Active Ingredient: Drostanolone Enanthate (Masteron)
Concentration: 200mg/ml
Package Size: 10 Ampoules (sterile glass)
Chemical Structure: Dihydrotestosterone + Enanthate ester
Half-Life: 7–10 days (Long-ester)
Recommended Dosage: 300–600mg per week (Men)
Administration: Intramuscular injection only
Aromatization: No (Anti-estrogenic)
Water Retention: No (Dry gains only)
Classification: Anabolic steroid
Cycle Duration: Typically 8–12 weeks
Detection Time: Up to 3 months

Where to Buy

Purchase authentic Pharmacom Labs DRO E 200mg/ml 10 Ampoules exclusively from verified underground labs
Source only from trusted steroid suppliers with established track records
Verify product authenticity using hologram verification codes on Pharmacom Labs packaging
Legitimate vendors provide laboratory testing documentation confirming purity and concentration
Avoid unverified sources selling counterfeit drostanolone products
Check batch numbers and ampoule integrity before use
Reputable bodybuilding supplement sources with third-party testing preferred

Safety Considerations

Drostanolone Enanthate suppresses natural testosterone production. Post-cycle therapy is mandatory. Regular blood work monitors lipid profiles and hormonal balance. Not suitable for women due to virilization risks.